Objective: The aim of this study was to prospectively evaluate the ability of a peritoneal equilibration test (PET) performed in the first week of peritoneal dialysis (PD) to predict subsequent transport status, as determined by a PET at 4 weeks and >1 year after PD commencement.

Design: Prospective observational study of an incident PD cohort at a single center.

Setting: Tertiary-care institutional dialysis center.

Participants: The study included 50 consecutive patients commencing PD at the Princess Alexandra Hospital between 25/2/2001 and 14/5/2003 (mean age 60.9 +/- 12.2 years, 54% male, 92% Caucasian, 38% diabetic). All patients were initially prescribed continuous ambulatory PD.

Main Measurements: Measurements performed during paired PETs included dialysate-to-plasma ratios of urea (D/P urea) and creatinine (D/P creatinine) at 4 hours, the ratio of dialysate glucose concentrations at 0 and 4 hours (D/D0 glucose), and drain volumes at 4 hours.

Results: When paired 1-week and 1-month PET data were analyzed, significant changes were observed in measured D/P urea (0.91 +/- 0.07 vs 0.94 +/- 0.07 respectively; p < 0.05), D/P creatinine (0.55 +/- 0.12 vs 0.66 +/- 0.11, p < 0.001), and D/D0 glucose (0.38 +/- 0.08 vs 0.36 +/- 0.10, p < 0.05). Using Bland-Altman analysis, the repeatability coefficients were 0.17, 0.20, and 0.13, respectively. Agreement between 1-week and 1-month PET measurements with respect to peritoneal transport category was moderate for D/D0 glucose (weighted kappa 0.52), but poor for D/P urea (0.30), D/P creatinine (0.35), and drain volumes (0.20). The PET measurements performed more than 1 year following PD commencement (n = 28) generally agreed closely with 1-month measurements, and poorly with 1-week measurements.

Conclusions: Peritoneal transport characteristics change significantly within the first month of PD. PETs carried out during this time should be considered preliminary and should be confirmed by a PET 4 weeks later. Nevertheless, performing an early D/D0 glucose measurement at 1 week predicted ultimate transport status sufficiently well to facilitate early clinical decision-making about optimal PD modality while patients were still receiving PD training. On the other hand, the widespread practice of using measured drain volumes in the first week to predict ultimate transport category is highly inaccurate and not recommended.

Download full-text PDF

Source

Publication Analysis

Top Keywords

d/d0 glucose
16
d/p urea
12
d/p creatinine
12
drain volumes
12
peritoneal equilibration
8
transport status
8
pet weeks
8
measurements performed
8
1-week 1-month
8
1-month pet
8

Similar Publications

Background: Peritoneal fibrosis is a serious complication of long-term peritoneal dialysis, often resulting in functional deterioration and withdrawal from therapy. Mesenchymal stem cells (MSCs) have demonstrated immunomodulatory and antifibrotic effects in various models. This meta-analysis evaluated the efficacy of MSCs therapy in animal models of peritoneal fibrosis.

View Article and Find Full Text PDF
Article Synopsis
  • - This study investigates how certain complement factors in the peritoneal effluents of patients undergoing continuous ambulatory peritoneal dialysis (CAPD) can predict the rate at which solutes are transported across the peritoneal membrane (PSTR).
  • - Researchers analyzed peritoneal effluents from CAPD patients using a protein array and ELISA techniques, finding correlations between levels of specific complement factors (like C2 and C4b) and PSTR metrics.
  • - Results indicate that the lectin pathway may be linked to peritoneal injury in dialysis patients, with the intraperitoneal level of Masp-1 identified as a key independent predictor of increased PSTR.
View Article and Find Full Text PDF

Based on a circular economy approach, we evaluated the possible effect of targeted supplementation with leftover feed from dairy cows (i.e., intensive system) on the reproductive performance of crossbred/rangeland goats (i.

View Article and Find Full Text PDF
Article Synopsis
  • Long-term peritoneal dialysis (PD) can impair peritoneal membrane function, possibly due to glucose degradation products accumulating.
  • A study suggests that far-infrared (FIR) therapy may help reduce these harmful products after 6 months.
  • This research evaluated FIR therapy's impact on PD patients, showing that it improved kidney function in lower transporters and decreased certain markers in higher transporters, indicating potential benefits for peritoneal membrane function.
View Article and Find Full Text PDF

Long-term peritoneal dialysis (PD) is accompanied by low-grade intraperitoneal inflammation and may eventually lead to peritoneal membrane injury with a high solute transport rate and ultrafiltration failure. Osteopontin (OPN) is highly expressed through the stimulation of pro-inflammatory cytokines in many cell types. This study aimed to investigate the potential of OPN as a new indicator of peritoneal deterioration.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!